Accessibility Menu
SPDR Series Trust - SPDR S&P Biotech ETF logo

SPDR Series Trust - SPDR S&P Biotech ETF(NYSEMKT) XBI

Current Price$152.18
Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)+880%
5 Year+21%
1 Year+76%
1 Month+4%
SPDR Series Trust - SPDR S&P Biotech ETF last closing stock price
MetricPriceDate
Last closeUSD 152.112026-07-22
SPDR Series Trust - SPDR S&P Biotech ETF stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.63%USD 156.222026-07-15
1 month+4.28%USD 145.862026-06-22
3 month+13.21%USD 134.362026-04-23
Year to date+24.87%USD 121.812025-12-31
1 year+76.18%USD 86.342025-07-22
3 year+80.15%USD 84.442023-07-21
5 year+21%USD 125.712021-07-23
Since inception+879.91%USD 15.522006-02-06

SPDR Series Trust - SPDR S&P Biotech ETF Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.57

Beta (Volatility)

1.17 (Average)

Price

$152.18

Volume

6,301,228

Open

$153.64

Previous Close

$152.11

Daily Range

$151.98 - $154.75

52-Week Range

$84.39 - $165.71

Estimated Earnings Date

N/A

XBI News

A scientist looking through a microscope.

5 Best Biotech ETFs for 2026 and How to Invest

Keith SpeightsJul 10, 2026
ETFvsETF-Purple.png

Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026?

Brendan CoffeyJul 9, 2026
ETFvsETF-Green.png

Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best?

Erin KennedyJul 5, 2026
ETFvsETF-Green.png

Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors?

Josh Kohn-LindquistJun 17, 2026
Woman using gloves to hold up and inspect a red pill.

Biotech vs. Pharma: What's the Difference?

Keith SpeightsJun 14, 2026
ETFvsETF-Blue.png

Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech

Jake LerchJun 5, 2026
ETFvsETF-Blue.png

VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost

Jake LerchMay 28, 2026
Biotech scientist working on a tablet with bio-related icons projected above it.

How to Invest in SPDR S&P Biotech ETF (XBI)

Rachel WarrenFeb 25, 2026
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SPDR Series Trust - SPDR S&P Biotech ETF

State Street SPDR S&P Biotech ETF is an exchange-traded fund that focuses on the biotechnology sector. Managed by State Street Global Advisors, this fund aims to track the performance of the S&P Biotechnology Select Industry Index.

Products and Services
  • Invests in U.S. public equity markets
  • Focuses on biotechnology, pharmaceuticals, and life sciences sectors
  • Utilizes representative sampling to track index performance
Growth Outlook
  • Market capitalization stands at approximately $8.07 billion
  • Recent trading volume reached over 11.5 million shares
  • Stock price fluctuated between $84.39 and $165.71 in the past year
Financial Highlights
  • Recent dividend yield is approximately 0.37%
  • Quarterly trading volume averaged over 8.9 million shares
  • Last dividend paid was $0.5713 per share
State Street SPDR S&P Biotech ETF offers a strategic investment opportunity in the growing biotechnology sector. The fund's focus on diverse market capitalization allows for exposure to both growth and value stocks. With a significant market presence and robust trading volume, the ETF is positioned to capitalize on trends within the healthcare and life sciences industries. The recent dividend yield and consistent trading activity reflect investor interest and confidence in the fund's performance.
AI Generated • Jul 19, 2026

Industry

Capital Markets

Sector

Financials

Headquarters

Boston, MA 2210, US

XBI Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.38%

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

6.30M

Avg. Volume

9.02M

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

SPDR Series Trust - SPDR S&P Biotech ETF Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KBWBInvesco KBW Bank ETF
$97.12+0.27%
AIQGlobal X - Artificial Intelligence & Technology ETF
$60.14-1.41%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$23.04+0.04%
ONDSOndas
$8.00+0.04%
SMCISuper Micro Computer
$30.56+0.20%
AALAmerican Airlines Group
$14.79-0.03%

Questions About XBI

What is the current price of SPDR Series Trust - SPDR S&P Biotech ETF?

SPDR Series Trust - SPDR S&P Biotech ETF is trading at $152.11 per share.

What is the 52-week range for SPDR Series Trust - SPDR S&P Biotech ETF?

Over the past 52 weeks, SPDR Series Trust - SPDR S&P Biotech ETF has traded between $84.39 and $165.71.

How much debt does SPDR Series Trust - SPDR S&P Biotech ETF have?

SPDR Series Trust - SPDR S&P Biotech ETF total debt is unavailable.

How much cash does SPDR Series Trust - SPDR S&P Biotech ETF have on hand?

SPDR Series Trust - SPDR S&P Biotech ETF does not have cash on hand data available.

What is SPDR Series Trust - SPDR S&P Biotech ETF’s dividend yield?

SPDR Series Trust - SPDR S&P Biotech ETF currently has a dividend yield of 0.38%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services